P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells. - Wikidata - wikimedia - TriplyDB

P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.

P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.

http://www.wikidata.org/entity/Q33530673

about

Exposure to carbon nanotubes leads to changes in the cellular biomechanics Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Cancer stem cells and drug resistance: the potential of nanomedicine Immunomodulation of nanoparticles in nanomedicine applications Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Carbon nanotubes as cancer therapeutic carriers and mediators Surface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicity Altered cell mechanics from the inside: dispersed single wall carbon nanotubes integrate with and restructure actin Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury Reducing Both Pgp Overexpression and Drug Efflux with Anti-Cancer Gold-Paclitaxel Nanoconjugates Non-metallic nanomaterials in cancer theranostics: a review of silica- and carbon-based drug delivery systems pH-sensitive nanocargo based on smart polymer functionalized graphene oxide for site-specific drug delivery.Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine.A new era of cancer treatment: carbon nanotubes as drug delivery tools.Computational design of a CNT carrier for a high affinity bispecific anti-HER2 antibody based on trastuzumab and pertuzumab Fabs.A cell-targeted, size-photocontrollable, nuclear-uptake nanodrug delivery system for drug-resistant cancer therapy Enhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles.Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells.Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.Self-assembled Multifunctional DNA Nanoflowers for the Circumvention of Multidrug Resistance in Targeted Anticancer Drug Delivery.Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics.Effect of nitrogen atomic percentage on N+-bombarded MWCNTs in cytocompatibility and hemocompatibility Targeting carbon nanotubes against cancer.Carbon nanotubes: applications in pharmacy and medicine.Nanomaterials for targeted drug delivery to cancer stem cells.Stimuli-responsive cancer therapy based on nanoparticles.Carbon nanotubes: potential medical applications and safety concerns.Advances in the biomedical application of polymer-functionalized carbon nanotubes.Revisiting the role of nanoparticles as modulators of drug resistance and metabolism in cancer.Carbon Nanotubes Disrupt Iron Homeostasis and Induce Anemia of Inflammation through Inflammatory Pathway as a Secondary Effect Distant to Their Portal-of-Entry.Carbon nanotubes in cancer therapy and drug delivery.Carbon nanotubes: a novel material for multifaceted applications in human healthcare.The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.Synthesis and evaluation of single-wall carbon nanotube-paclitaxel-folic acid conjugate as an anti-cancer targeting agent.Reversing resistance of multidrug-resistant hepatic carcinoma cells with parthenolide.Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study.Bypassing multidrug resistance in cancer cells with biodegradable polymer capsules.Antibody covalent immobilization on carbon nanotubes and assessment of antigen binding.Therapeutics formulated to target cancer stem cells: Is it in our future?

P2860

Q23911034-F5735F38-56FB-4466-A4DE-82F586896E13 Q26830028-60D42CD3-0989-40C9-AC38-97466D8A40C6 Q26998993-94065E4F-5AD3-47E5-8A55-64600E993E5E Q27021145-9C4C72CE-897B-4947-8927-81DBC70FBD1C Q28073956-15AFF379-C2CD-4456-937F-8DC36D627655 Q28074309-0F73C7B2-7519-474A-93F7-7651EF76EC6F Q28385356-BD5CD1B8-ACFC-4433-B20D-302970C65433 Q28387306-CDB3EF65-515A-45FC-B385-0E3E5FA75640 Q28392985-652FDBDE-963B-4F89-9E6C-5B83DADFCF1B Q28553214-AD346A3A-3F83-4B02-A023-AE0DFE5B4023 Q28822460-7AC35539-52EA-414E-99A3-E275E4E169AF Q30596446-A08C1970-F64E-434C-8DF5-D52F25025FB6 Q34011106-1AAAB091-52F0-407A-A62A-A3912AC7BC73 Q34033804-322E2EEC-467E-47A6-B58C-7BF1B5C5457E Q34097540-7D8D9975-5888-4F5C-817A-081B969A897F Q34473476-4C5FD191-7002-47F2-A2B4-A8E707100B60 Q34977497-E2CD8CDE-EEA7-4B44-866E-C0F24D02B939 Q35574213-DE2BB89E-2D8E-48B8-9B5C-CF633A0DD908 Q35918956-62DA9ECF-2AB1-4114-BA81-62BD67564E15 Q37031597-0991548C-6A88-4DC5-839B-7C43D103F2E7 Q37351040-E15B61B4-8AEC-4DB0-A439-42325D48439E Q37404658-99CFE425-EF04-4238-90E8-A41AEBFF2109 Q37703417-532D4EE8-0754-4F08-BA5F-7327A312BD61 Q37994689-AFA71B04-00AE-4C55-84D4-B8020FD480EE Q38160231-27054DE5-C8E5-4687-A543-F171BBE01C2E Q38201740-FFE7705D-A1E6-483B-8CD6-7070F6F770AC Q38233457-57079837-FD8B-4A7E-B3A7-F197C4096D42 Q38272075-EEA4AC8A-F8E1-4C8D-AAF7-637911B70C5C Q38556891-5381C21E-D408-4A94-9964-1D6ADBA40C42 Q38707907-74C25F3D-AC96-44A5-B0C8-FB3D9EDD59BD Q38757812-2ECF357C-3739-4101-B7E2-4A17C1F55705 Q38790433-F04FF61D-C998-471E-8F02-9483508E54BC Q38795672-6CCE6687-5FE3-47D9-94FF-97F89385709E Q38809044-8A02DFA2-F4F7-4C72-8741-D36A1BA7599A Q38898321-862CB923-E9C4-401C-94B4-3E0B1A0C520F Q39170794-1ADCB60F-BAB0-402A-9EE5-6ADF7D19B526 Q39567982-2DB3D51D-D23B-43E8-AC6B-B9F7783DEB65 Q39639787-2A2964E8-926E-46C0-A4B9-29F9F4942A11 Q39747061-9E001F60-3CDA-4E2C-8788-53D4E1EC610A Q39767667-F4D9E007-B0BC-466A-9650-3A4F1AE1DCC2

P2860

P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.

http://www.wikidata.org/entity/Q33530673

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

P-glycoprotein antibody functi ...... tance of human leukemia cells.

@ast

P-glycoprotein antibody functi ...... tance of human leukemia cells.

@en

P-glycoprotein antibody functi ...... tance of human leukemia cells.

@nl

type

label

P-glycoprotein antibody functi ...... tance of human leukemia cells.

@ast

P-glycoprotein antibody functi ...... tance of human leukemia cells.

@en

P-glycoprotein antibody functi ...... tance of human leukemia cells.

@nl

prefLabel

P-glycoprotein antibody functi ...... tance of human leukemia cells.

@ast

P-glycoprotein antibody functi ...... tance of human leukemia cells.

@en

P-glycoprotein antibody functi ...... tance of human leukemia cells.

@nl

P1433

Q33530673-57164C48-6F00-416E-9872-DF82A821AB97

P1476

Q33530673-83CA696A-3D13-4CEA-822B-E7FD4573B679

P2093

Q33530673-11A60E55-9F80-4C3C-8C76-D5088D1ABF0B

Q33530673-3D44675C-5FB3-43AA-AAE3-52E375E20C1F

Q33530673-85327FC9-7BF0-46CB-8649-E3C74EE3D44C

Q33530673-93DFB79D-49FE-47B1-AACF-5D1489A9C9EA

Q33530673-9A971283-F037-4BE3-87F3-C61EA7B055DB

Q33530673-B0844C3E-1CAA-476E-974D-49B20D9A14CD

P304

Q33530673-434A90F0-2524-44C2-B61A-68E42BA6F210

P31

Q33530673-92C411F1-E912-414C-986F-C38506C7BD3D

P356

Q33530673-06B1961B-BD47-41CD-A33A-695ACADAA6AA

P407

Q33530673-4C9B41E3-A533-421B-AC2D-06A26371B58B

P433

Q33530673-E7972AFD-80FC-4C10-9EC2-2A95326107F8

P478

Q33530673-24CABBE9-F2A9-4EBF-9921-AFB2F2EA7FC8

P577

Q33530673-4AA80EC3-2E60-4F15-8E84-36919897DA3F

P5875

Q33530673-A03EDD33-5934-4995-9016-E0A0FD0306D3

P698

Q33530673-5DAF8C08-CAD0-4C75-ABDF-5AF457FE43C7

P921

Q33530673-65DD10DD-3218-488B-8144-036D1C7C1B04

Q33530673-761AA60D-B9D4-43DD-8F1B-CCDACC421137

Q33530673-9A2C5E18-228E-463B-A415-C32823EE56A6

Q33530673-E280C7DF-828F-4206-A5F9-8316C939ADD9

P356

P1433

P1476

P-glycoprotein antibody functi ...... tance of human leukemia cells.

@en

P2093

Hanfa Zou

http://www.w3.org/2001/XMLSchema#string

Liang Zhao

http://www.w3.org/2001/XMLSchema#string

Ling Yang

http://www.w3.org/2001/XMLSchema#string

Minghuo Wu

http://www.w3.org/2001/XMLSchema#string

Ren'an Wu

http://www.w3.org/2001/XMLSchema#string

Ruibin Li

http://www.w3.org/2001/XMLSchema#string

P304

1399-1408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/NN9011225

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41423004

http://www.w3.org/2001/XMLSchema#string

P698

20148593

http://www.w3.org/2001/XMLSchema#string

P921

carbon nanotube

multiple drug resistance